Short Interest in BioRestorative Therapies, Inc. (NASDAQ:BRTX) Increases By 205.8%

BioRestorative Therapies, Inc. (NASDAQ:BRTX) was the target of a significant increase in short interest in February. As of February 28th, there was short interest totalling 715,900 shares, an increase of 205.8% from the February 13th total of 234,100 shares. Based on an average daily trading volume, of 390,000 shares, the days-to-cover ratio is currently 1.8 days. Currently, 14.3% of the shares of the stock are sold short.

BioRestorative Therapies Stock Up 9.3 %

NASDAQ:BRTX opened at $1.77 on Friday. BioRestorative Therapies has a 52-week low of $1.03 and a 52-week high of $2.55. The stock has a fifty day simple moving average of $1.97 and a 200-day simple moving average of $1.71. The company has a market capitalization of $12.25 million, a PE ratio of -1.16 and a beta of 64.37.

Hedge Funds Weigh In On BioRestorative Therapies

A hedge fund recently bought a new stake in BioRestorative Therapies stock. Citadel Advisors LLC acquired a new position in shares of BioRestorative Therapies, Inc. (NASDAQ:BRTX) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 21,481 shares of the company’s stock, valued at approximately $31,000. Citadel Advisors LLC owned approximately 0.31% of BioRestorative Therapies at the end of the most recent reporting period. 69.38% of the stock is owned by hedge funds and other institutional investors.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.